Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
DYN
Dyne Therapeutics, Inc.
NASDAQ · Pharmaceutical Preparations
Last close
$16.11
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$3.01B
RECENT INSIDER TRADES
2026-10-06
· Posner Brian S
(Director)
· BUY
2026-09-08
· Friedl-Naderer Johanna
(Chief Commercial Officer)
· SELL
2026-09-08
· Cox John
(CEO & President)
· SELL
2026-09-08
· Kerr Douglas
(Chief Medical Officer)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
264
Shares held
224,447,029
Value
$4.21B
Percent of shares outstanding
120.19%
As of quarter end
2026-06-30
RECENT NEWS
Stifel reiterates Dyne Therapeutics stock rating on trial data
Jefferies reiterates Dyne Therapeutics stock rating on trial data
Dyne Therapeutics stock rises on positive DM1 trial results
Dyne Therapeutics reports one-year Phase 1/2 data for Z-Basivarsen in myotonic dystrophy
DYN: Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Dyne Therapeutics, Inc. (DYN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit